We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Beating Heart Surgery Preferred to Heart-lung Machine

By HospiMedica staff writers
Posted on 13 Feb 2007
Coronary artery bypass surgery performed on a beating heart, without the aid of a heart-lung machine, is a safe option that leads to fewer negative side effects for bypass patients, according to a new study.

According to a review of the latest clinical trials by two cardiac surgeons, performing delicate coronary anastomoses with off-pump coronary artery bypass (OPCAB) surgery, while more technically challenging for the surgeon, keeps side effects low and allows for a quicker recovery when compared to surgery performed with a cardiopulmonary bypass (CPB). More...
The review was published online on January 23, 2007, in the Journal of Cardiac Surgery.

"Previously, it was more common for doctors to perform artery bypass surgery on the heart by stopping the heart and passing the blood through a heart-lung machine,” said lead author Dr. Shahzad Raja of the department of cardiothoracic surgery at the Royal Hospital for Sick Children (Glasgow, Scotland). "However, this process frequently leads to ‘whole body inflammation,' which includes complications such as brain swelling, heart arrhythmia, and infections.”

"If the surgeons are skilled enough to perform the surgery without stopping the heart, it can be offered to high-risk patients who would not be likely to survive the side effects of the traditional stopped-heart method,” continued Dr. Raja. "For this reason, quality training needs to be provided for those surgeons who wish to offer this option to their patients.”





Related Links:
Royal Hospital for Sick Children Glasgow

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.